1.

Latent tuberculosis infection in foreign-born communities: Import vs. transmission in The Netherlands derived through mathematical modelling

1.

Increased carriage of non-vaccine serotypes with low invasive disease potential four years after switching to the 10-valent pneumococcal conjugate vaccine in The Netherlands

1.

The prevalence of adverse postnatal outcomes for mother and infant in the Netherlands

1.

Heterogeneous impact of soil contamination on farmland prices in the Belgian Campine region : evidence from unconditional quantile regressions

2.

Heterogeneous impact of soil contamination on farmland prices in the Belgian Campine region : evidence from unconditional quantile regressions

3.

Heterogeneous impact of soil contamination on farmland prices in the Belgian Campine region : evidence from unconditional quantile regressions

4.

Heterogeneous impact of soil contamination on farmland prices in the Belgian Campine region : evidence from unconditional quantile regressions

1.

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

2.

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

3.

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

4.

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

5.

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

6.

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

7.

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

8.

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

9.

Investigating the role of ALS genes CHCHD10 and TUBA4A in Belgian FTD-ALS spectrum patients

1.

Belgian flood risk governance : explaining the dynamics within a fragmented governance arrangement

2.

Belgian flood risk governance : explaining the dynamics within a fragmented governance arrangement

3.

Belgian flood risk governance : explaining the dynamics within a fragmented governance arrangement

4.

Belgian flood risk governance : explaining the dynamics within a fragmented governance arrangement

1.

NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

2.

NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

3.

NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

4.

NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

5.

NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

6.

NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

7.

NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

8.

NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

9.

NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients

1.

Extended FTLD pedigree segregating a Belgian GRN-null mutation : neuropathological heterogeneity in one family

2.

Extended FTLD pedigree segregating a Belgian GRN-null mutation : neuropathological heterogeneity in one family

3.

Extended FTLD pedigree segregating a Belgian GRN-null mutation : neuropathological heterogeneity in one family

4.

Extended FTLD pedigree segregating a Belgian GRN-null mutation : neuropathological heterogeneity in one family

1.

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

2.

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

3.

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

4.

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

5.

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

6.

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

7.

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

8.

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

9.

Clinical variability and onset age modifiers in an extended Belgian GRN founder family

1.

A retrospective Belgian multi-center MRI biomarker study in Alzheimers disease (REMEMBER)

2.

A retrospective Belgian multi-center MRI biomarker study in Alzheimers disease (REMEMBER)

3.

A retrospective Belgian multi-center MRI biomarker study in Alzheimers disease (REMEMBER)

4.

A retrospective Belgian multi-center MRI biomarker study in Alzheimers disease (REMEMBER)